Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
Yukio SuzukiYongmei HuangJennifer FerrisAmita KulkarniDawn HershmanJason D WrightPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
HRT was prescribed to less than half of patients with newly diagnosed cervical cancer under the age of 50 who experienced premature menopause due to primary treatment. Among those who used HRT the duration of use was short.